PEIJIA MEDICAL LIMITED Financials Peijia Medical Limited
Equities
9996
KYG6981F1090
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.66 HKD | -3.94% |
|
-.--% | -50.47% |
| Apr. 08 | JenaValve Technology, Inc. announced that it has received $100.4 million in funding from a group of investors | CI |
| Apr. 02 | Peijia Medical Limited Delays in Publication of 2023 Annual Results | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 15,022 | 7,261 | 5,677 | 2,282 | 2,282 | - |
| Enterprise Value (EV) 1 | 12,573 | 4,972 | 4,140 | 4,536 | 1,802 | 2,098 |
| P/E ratio | - | -12.6 x | -13.8 x | -11.6 x | -9.39 x | -28.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 389 x | 53.2 x | 22.6 x | 10.3 x | 3.35 x | 2.43 x |
| EV / Revenue | 325 x | 36.4 x | 16.5 x | 10.3 x | 2.64 x | 2.24 x |
| EV / EBITDA | -32.7 x | -23 x | -8 x | -12.1 x | -10.1 x | -35.5 x |
| EV / FCF | -60.9 x | -9.82 x | -7.16 x | -2.73 x | -3.88 x | -7.44 x |
| FCF Yield | -1.64% | -10.2% | -14% | -36.7% | -25.8% | -13.4% |
| Price to Book | 5.33 x | 2.39 x | 2.15 x | 0.98 x | 1.15 x | 1.19 x |
| Nbr of stocks (in thousands) | 632,918 | 670,013 | 672,429 | 675,331 | 675,331 | - |
| Reference price 2 | 23.73 | 10.84 | 8.443 | 3.380 | 3.380 | 3.380 |
| Announcement Date | 3/29/21 | 3/31/22 | 3/31/23 | 3/28/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 38.66 | 136.5 | 250.8 | 441.1 | 681.6 | 937.8 |
| EBITDA 1 | -384.2 | -215.8 | -517.2 | -375.8 | -177.9 | -59.03 |
| EBIT 1 | -403.7 | -243.3 | -562 | -434.7 | -278 | -102.7 |
| Operating Margin | -1,044.41% | -178.22% | -224.05% | -98.54% | -40.79% | -10.96% |
| Earnings before Tax (EBT) 1 | - | -574.2 | -398.2 | -391.5 | -246.1 | -80.89 |
| Net income 1 | - | -574.2 | -407.8 | -392.5 | -246.1 | -80.89 |
| Net margin | - | -420.57% | -162.58% | -88.98% | -36.1% | -8.63% |
| EPS 2 | - | -0.8600 | -0.6100 | -0.5800 | -0.3600 | -0.1200 |
| Free Cash Flow 1 | -206.4 | -506.1 | -578.5 | -512 | -465 | -282 |
| FCF margin | -533.84% | -370.68% | -230.65% | -110.26% | -68.22% | -30.07% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 3/29/21 | 3/31/22 | 3/31/23 | 3/28/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 2,449 | 2,288 | 1,538 | 887 | 480 | 184 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -206 | -506 | -579 | -512 | -465 | -282 |
| ROE (net income / shareholders' equity) | -34.9% | -8.9% | -18.2% | -12.9% | -10.6% | -5.98% |
| ROA (Net income/ Total Assets) | -20.9% | - | -15.9% | -9.11% | - | - |
| Assets 1 | - | - | 2,568 | 3,874 | - | - |
| Book Value Per Share 2 | 4.450 | 4.530 | 3.920 | 3.450 | 2.950 | 2.830 |
| Cash Flow per Share 2 | - | - | -0.5600 | -0.4900 | - | - |
| Capex 1 | 25.3 | 69.7 | 202 | 265 | 296 | 318 |
| Capex / Sales | 65.33% | 51.08% | 80.67% | 57.12% | 43.43% | 33.91% |
| Announcement Date | 3/29/21 | 3/31/22 | 3/31/23 | 3/28/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.38
CNY
Average target price
11.1
CNY
Spread / Average Target
+228.38%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -50.47% | 316M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 9996 Stock
- Financials Peijia Medical Limited
